Trump’s Kentucky Visit: Promises, Protests, and Political Races
President Donald Trump announced a plan for a $100 million investment in pharmaceutical manufacturing in Kentucky, with conditions based on the Republican success in the upcoming midterm elections. Speaking at a rally in Highland Heights, he stated, “If the Republicans win, the Department of War will invest $100 million in the pharmaceutical company Antheia to revitalize a large drug manufacturing facility in Winchester, Kentucky.” The rally, held at Northern Kentucky University’s Truist Arena, was part of a push for Republican candidates, including Senate hopeful Andy Barr and 4th Congressional District candidate Ed Gallrein, who had earlier defeated incumbent Thomas Massie with Trump’s endorsement.
Trump linked the proposed investment directly to the midterm results, leaving details about the investment’s structure and timing unclear. Newsweek sought comments from Antheia for further details on the proposal.
Manufacturing and economic improvements were central to Trump’s speech. He predicted significant economic gains with the opening of new plants. “Those plants are going to be opening in a year, and when they open you’re going to see numbers that nobody’s ever seen before,” Trump remarked.
Antheia’s Role in Pharmaceuticals
Antheia, located in California, produces key starting materials (KSMs) and active pharmaceutical ingredients (APIs) crucial for essential medicines. Its biosynthesis technology aims to provide a reliable alternative to agricultural-based supply chains that can suffer from poor yields and other interruptions.
The company’s first commercial product is thebaine, used to manufacture medications for severe pain, overdose reversal, and addiction treatment. Antheia expects its first commercial thebaine delivery in 2024. The company is also developing ingredients like oripavine and scopolamine.
Trump’s announcement coincided with a wider federal initiative to boost domestic production of pharmaceutical ingredients. In March, Antheia received a $9 million award from the Department of Health and Human Services to expand thebaine production domestically due to concerns over reliance on foreign supply chains.
Previously, Antheia secured up to $12 million in support through a government-backed deal under the HHS’ Defense Production Act Title III program. The proposed $100 million investment Trump mentioned would significantly exceed previous federal commitments, though details about the Winchester project remain undisclosed.
Addressing Foreign Affairs and Protests
During the rally, Trump addressed the ongoing conflict with Iran, saying, “It’s going to end very quickly.” He referred to U.S. actions as an “excursion” and described a confrontation with Iran using strong language.
The rally witnessed a brief interruption by a protester, whom security removed. Trump suggested the protester was paid and deliberated on whether to press charges, ultimately deciding against it based on crowd reactions.
The rally continued with disruptions, including another individual who Trump questioned as either “friend or foe,” highlighting the intensity of the atmosphere.
In a broader speech, Trump discussed international economic interests, specifically mentioning profits from Venezuela, saying “Hundreds of billions of dollars we’re taking out of Venezuela.”
Competitive Kentucky Races
With Senator Mitch McConnell not seeking reelection, Kentucky voters are assessing candidates for his seat. Andy Barr competes against Democrat Charles Booker. A recent poll by Global Strategy Group indicated Barr leading by 49 percent to 40 percent, with a 4 percent error margin.
The 6th Congressional District race features Republican Ralph Alvarado against Democrat Zach Dembo. A Change Research poll reported Dembo leading with 47 percent to 38 percent, with 8 percent undecided. The poll had a 4.4 percent margin of error.
Additional focus is on the 4th Congressional District race, where Ed Gallrein competes against Democrat Melissa Strange, though recent polling is unavailable.